Cargando…

Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference

Prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase 2 (COX-2), plays a critical role in many normal physiological functions and modulates a variety of pathological conditions. The ability to turn endogenous COX-2 on and off in a reversible fashion, at specific times and in sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaiss, Anne K., Zuber, Johannes, Chu, Chun, Machado, Hidevaldo B., Jiao, Jing, Catapang, Arthur B., Ishikawa, Tomo-o, Gil, Jose S., Lowe, Scott W., Herschman, Harvey R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079684/ https://www.ncbi.nlm.nih.gov/pubmed/24988319 http://dx.doi.org/10.1371/journal.pone.0101263

Ejemplares similares

Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies()
por: Kirkby, Nicholas S., et al.
Publicado: (2013)

In Vivo Mouse Bioluminescence Tomography with Radionuclide-Based Imaging Validation
por: Lu, Yujie, et al.
Publicado: (2010)

Hepatic Ischemia and Reperfusion Injury in the Absence of Myeloid Cell-Derived COX-2 in Mice
por: Duarte, Sergio, et al.
Publicado: (2014)

LC-MS/MS Confirms That COX-1 Drives Vascular Prostacyclin Whilst Gene Expression Pattern Reveals Non-Vascular Sites of COX-2 Expression
por: Kirkby, Nicholas S., et al.
Publicado: (2013)

Expression of cyclooxygenase-2 (COX-2) in pituitary tumours
por: Sokołowski, Grzegorz, et al.
Publicado: (2012)

Radiochemistry on electrodes: Synthesis of an (18)F-labelled and in vivo stable COX-2 inhibitor
por: Lebedev, Artem, et al.
Publicado: (2017)

Conditional Bicistronic Cre Reporter Line Expressing Both Firefly Luciferase and β-galactosidase
por: Ishikawa, Tomo-o, et al.
Publicado: (2010)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
por: Xu, Shili, et al.
Publicado: (2018)

Pancreatic Stellate Cells (PSCs) express Cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs
por: Yoshida, Seiya, et al.
Publicado: (2005)

The Spatiotemporal Role of COX-2 in Osteogenic and Chondrogenic Differentiation of Periosteum-Derived Mesenchymal Progenitors in Fracture Repair
por: Huang, Chunlan, et al.
Publicado: (2014)

Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
por: Einhorn, Thomas A
Publicado: (2003)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
por: Rawat, Chitra, et al.
Publicado: (2019)

Bioactivity of dihydropyrimidinone derivatives as inhibitors of cyclooxygenase-2 (COX-2): an in silico approach
por: Haq, Kautsar Ul, et al.
Publicado: (2023)

Nucleobindin Co-Localizes and Associates with Cyclooxygenase (COX)-2 in Human Neutrophils
por: Leclerc, Patrick, et al.
Publicado: (2008)

Parathyroid Hormone Induction of Cyclooxygenase-2 in Murine Osteoblasts: Role of the Calcium-Calcineurin-NFAT Pathway
por: Huang, Hechang, et al.
Publicado: (2010)

Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?
por: Zidar, Nina, et al.
Publicado: (2009)

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2006)

Regional Differences in the Neuronal Expression of Cyclooxygenase-2 (COX-2) in the Newborn Pig Brain
por: Oláh, Orsolya, et al.
Publicado: (2012)

Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice
por: Kim, Joohwee, et al.
Publicado: (2016)

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Sethi, Rickinder, et al.
Publicado: (2019)

The Search for Cyclooxygenase-2 (COX-2) Inhibitors for the Treatment of Inflammation Disease: An in-silico Study
por: Ruslin, Ruslin, et al.
Publicado: (2022)

Binding Energy Calculation of Patchouli Alcohol Isomer Cyclooxygenase Complexes Suggested as COX-1/COX-2 Selective Inhibitor
por: Raharjo, Sentot Joko, et al.
Publicado: (2014)

Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer
por: Cox, D G, et al.
Publicado: (2004)

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications
por: Ferrandina, G, et al.
Publicado: (2002)

Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus
por: Bhandari, Pradeep, et al.
Publicado: (2006)

PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model
por: Tietz, Ole, et al.
Publicado: (2016)

Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Westwell-Roper, Clara, et al.
Publicado: (2020)

In-vitro and computational analysis of Urolithin-A for anti-inflammatory activity on Cyclooxygenase 2 (COX-2)
por: Revankar, Archana G., et al.
Publicado: (2023)

Acyl chain-dependent effect of lysophosphatidylcholine on cyclooxygenase (COX)-2 expression in endothelial cells
por: Brkić, Lada, et al.
Publicado: (2012)

Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney
por: Pelligand, L., et al.
Publicado: (2015)

The Influence of Glycosylation of Natural and Synthetic Prenylated Flavonoids on Binding to Human Serum Albumin and Inhibition of Cyclooxygenases COX-1 and COX-2
por: Tronina, Tomasz, et al.
Publicado: (2017)

Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
por: Mohsin, Noor ul Amin, et al.
Publicado: (2022)

Flavocoxid Inhibits Phospholipase A2, Peroxidase Moieties of the Cyclooxygenases (COX), and 5-Lipoxygenase, Modifies COX-2 Gene Expression, and Acts as an Antioxidant
por: Burnett, Bruce P., et al.
Publicado: (2011)

Prostacyclin mediates endothelial COX-2-dependent neuroprotective effects during excitotoxic brain injury
por: An, Ying, et al.
Publicado: (2014)

Three-dimensional structure of human cyclooxygenase (hCOX)-1
por: Miciaccia, Morena, et al.
Publicado: (2021)

Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2008)

COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease
por: Crofford, Leslie J
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_k8a2089i2pdhku90bv3la6ail7